IBM, Walmart, Merck, KPMG partner for FDA’s blockchain program

On June 13, IBM, KPMG, Merck and Walmart announced that they have been selected by the FDA to evaluate the use of blockchain for identifying, tracking and tracing prescription drugs.

Advertisement

The U.S. Drug Supply Chain Security Act was created to better monitor prescription drugs and vaccines in the country. The program is intended to assist drug supply chain stakeholders in developing interoperable systems.

Blockchain is one technology that is being tested. The four companies will create a shared permissioned blockchain network that allows real-time monitoring of prescription medicines.

The new blockchain is intended to reduce the time needed to track and trace inventory, allow timely retrieval of reliable distribution information, increase accuracy of shared data, and help determine the integrity of the products.

More articles about health IT:
Noninvasive laser detects, kills melanoma cells in bloodstream
How to protect your at-home DNA test data
Carilion Clinic developing virtual toolset to improve opioid addiction care

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.